Is sentinel lymph node biopsy necessary in the setting of microinvasive DCIS?

Background: Breast cancer treatment guidelines recommend the surgeon perform a sentinel lymph node biopsy (SLNB) for patients with ductal carcinoma in situ (DCIS) who have a high risk of invasive cancer or for whom a mastectomy is planned.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Tags: POSTERS A: Optimal Diagnosis Source Type: research